Tests inpatient pulmonary rehabilitation in older adults with COPD flare-ups
Tests early lung rehabilitation exercises in people aged 65 to 78 with COPD flare-ups.
Plain-language title generated from the registry record
Registry title: Efficacy Of Inpatient Pulmonary Rehabilitation Program In Elderly Patients With Acute Exacerbation Of COPD
Key facts
- Where
- Cairo, EgyptSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 65 and 78 years old?
Source: NCT07020182, who can take part
Where in Egypt
- Faculty of Medicine for Girls- Al-Azhar-University, Cairo, EgyptCairo, EgyptNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Al-Azhar University
- Trial code
- NCT07020182
- Record updated
- 13 June 2025
- Original description
The study aimed to identify the effect of early pulmonary rehabilitation in elderly patients with Acute exacerbation (AE) of COPD (AECOPD) in exercise tolerance, dyspnea, sleep quality, fatigue, and time to discharge from hospital.Read full original descriptionShow less
Efficacy Of Inpatient Pulmonary Rehabilitation Program In Elderly Patients With Acute Exacerbation Of COPD
The study aimed to identify the effect of early pulmonary rehabilitation in elderly patients with Acute exacerbation (AE) of COPD (AECOPD) in exercise tolerance, dyspnea, sleep quality, fatigue, and time to discharge from hospital.
Inclusion: Patients with acute exacerbation of COPD in both gender; Patient older than 65 years; Patient with clear consciousness; Patients had been diagnosed with shortness of breath or dyspnea that was not caused by heart disease, pneumothorax, or pulmonary edema.
Exclusion: Patient with systolic blood pressure lower than 90 mmHg; Patient with an unstable psychological status, hemoptysis, pneumothorax, pulmonary edema.